Man meditating at home
CanvaPro/Hispanholistic

COVID-19

Journal Abstracts
Dec 22, 2025

COVID-19

Meditation May Improve Immune Function

Journal Abstracts
Dec 22, 2025

This 2023 study examined whether blood samples taken from participants before and after an intensive meditation retreat showed changes that could influence immune and inflammatory responses related to COVID-19.

For the study, novice meditators, experienced meditators, and non-meditating controls took part in a 7-day intensive meditation retreat, after which blood samples were collected before and after the program. Researchers then used these blood samples in laboratory tests to examine how meditation-related biological changes might influence immune responses.

Researchers found that post-meditation blood plasma altered inflammatory signaling and cellular stress responses in laboratory models, suggesting that meditation is associated with physiological changes to the immune system that may have potential therapeutic relevance. The authors emphasize that findings are preliminary and do not establish meditation as a standalone treatment for COVID-19 or any other virus, but rather as a possible complementary approach warranting further clinical study.

The authors selected several key highlights from the study:

  • Duration of meditation practice may affect vulnerability to and recovery from COVID-19.
  • Blood plasma from experienced meditators reduces viral infection in lab-cultured lung cells.
  • Meditation is associated with increased SERPINA5, a group of genes involved in immune regulation.
  • Consistent meditation practice may enhance well-being through measurable biological changes.

The meditation retreats where participants were observed were organized and run by Encephalon, a company founded by Dr. Joe Dispenza, who is also a co-author on the paper. The authors disclose this relationship as a potential conflict of interest, and results should be interpreted with this context in mind.

REFERENCES

Zuniga-Hertz, J. P., Chitteti, R., Dispenza, J., Cuomo, R., Bonds, J. A., Kopp, E. L., Simpson, S., Okerblom, J., Maurya, S., Rana, B. K., Miyonahara, A., Niesman, I. R., Maree, J., Belza, G., Hamilton, H. D., Stanton, C., Gonzalez, D. J., & Poirier, M. A. (2023). Meditation-induced bloodborne factors as an adjuvant treatment to COVID-19 disease. Brain, Behavior, and Immunity – Health, 32, Article 100675. https://doi.org/10.1016/j.bbih.2023.100675

Advanced Search on this topic

Other Articles in this category

Dec 17, 2025 | COVID-19
Fermented foods have been used across cultures for centuries, not only to preserve foods but also to support health. During fermentation, natural…
Dec 09, 2025 | COVID-19
A 2025 study of 114 American Indian and Alaska Native teenagers living in California examined how their health was changed by the COVID-19 pandemic…
Nov 05, 2025 | COVID-19
Black women in the United States face disproportionately high rates of maternal mortality and morbidity. The Centers for Disease Control and…
Oct 24, 2025 | COVID-19
A 2024 study published in the Journal of Nutritional Science and Vitaminology (Tokyo) investigated whether creatine supplementation could help…

Customer Service

KnoWEwell News Updates